Regeneron Pharmaceuticals, Inc., one of the fastest-growing companies in the global biotechnology industry, has announced further expansion of its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus with an additional 300 jobs and investment of $100 million, bringing the total expected employment at the site to 800 people and total investment to $750 million. The project is supported by the government through IDA Ireland.
As Regeneron’s Irish expansion continues with employment expected to rise to 800 by the end of 2018, recruitment is ongoing for high-end specialist positions in commercial manufacturing, process sciences, quality assurance/control/validation and various support functions.
Regeneron’s 400,000 square foot, state-of-the-art production facility in Limerick is the largest scale bulk biologics production facility in Ireland and one of the largest biologic production operations in the world. The additional $100 million investment will support the construction of a number of manufacturing suites to increase drug substance production capacity and enable the company to meet demand for its life-transforming medicines for patients with serious diseases.
Get a FREE Digital Subscription!Enjoy full access to Hospitality Ireland, our weekly email news digest, all website and app content, and every digital issue.
Welcoming the investment and jobs announcement Taoiseach Leo Varadkar said, "Regeneron’s decision to expand so significantly is testament to the talent pool and attractive business environment available to companies in Ireland. This planned further expansion by Regeneron in Limerick is a significant contribution to the rejuvenation of the region."
Meanwhile, Niall O’Leary, Vice President and Site Head, IOPS Raheen, asserted, "Limerick offers an exceptionally good location for U.S. multinationals. Located just 30 minutes from Shannon Airport with a five hour time difference from New York, Ireland is also a midway point for U.S. executives linking into our partners, such as Bayer in Germany and Sanofi in France. In addition, the very favourable business environment along with the support provided by IDA Ireland and Limerick City and County Council make the city an ideal home for Regeneron."
In addition to the production facility in Limerick, Regeneron’s European business operations for IOPS, the company has a growing Dublin office, currently employing 30 people and serving as the company’s European business administration headquarters. Regeneron’s total headcount in Ireland is expected to approach 850 by the end of 2018.